Irinoliquid
Replacement
|
Medicines
|
08/07/2011
In a letter dated July 7, 2011, the marketing authorization holder informed its customers that stability tests had revealed that the active ingredient content had been exceeded and that the batch concerned would therefore be replaced as a precautionary measure.
| Name of the medicinal product | Irinoliquid 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | 1-29279 |
| Marketing authorisation holder | EBEWE Pharma Ges.m.b.H. Nfg.KG |
| Batch number(s) | 95977814 |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-0178 |
Further inquiry note
Page last modified:
12/07/2022